Innovating Treatments for Rare Neurological Disorders
Nospharma is a preclinical stage therapeutics company developing innovative treatments for rare genetic neurological disorders.
We aim to deliver novel and effective therapeutics as quickly as possible to make a lasting difference in the lives of millions of patients and their caring families.
Science
Our deep understanding of the human brain and cellular biology of rare genetic neurological disorders enables us to create meaningful therapies to treat them.
Pipeline
Our pipeline includes new treatment candidates for rare neurological conditions that are addressing genetically defined markets with major unmet needs.
Leadership
With over 35 years of combined expertise in neuroscience, our leadership is committed to building impactful therapeutics that improve the lives of people and families affected by rare neurological disorders.
News
Contact us
Talk to us to learn more about our partnership and business opportunities. Together, we can develop meaningful therapies for rare neurological disorders.